JP2000504730A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000504730A5 JP2000504730A5 JP1997529602A JP52960297A JP2000504730A5 JP 2000504730 A5 JP2000504730 A5 JP 2000504730A5 JP 1997529602 A JP1997529602 A JP 1997529602A JP 52960297 A JP52960297 A JP 52960297A JP 2000504730 A5 JP2000504730 A5 JP 2000504730A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60199296A | 1996-02-15 | 1996-02-15 | |
| US08/601,992 | 1996-02-15 | ||
| PCT/US1997/002678 WO1997030054A1 (en) | 1996-02-15 | 1997-02-14 | Pharmaceutically active compounds and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000504730A JP2000504730A (ja) | 2000-04-18 |
| JP2000504730A5 true JP2000504730A5 (enrdf_load_stackoverflow) | 2004-11-18 |
Family
ID=24409543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9529602A Ceased JP2000504730A (ja) | 1996-02-15 | 1997-02-14 | 製薬学的活性物質及び使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0925300A1 (enrdf_load_stackoverflow) |
| JP (1) | JP2000504730A (enrdf_load_stackoverflow) |
| KR (1) | KR19990082494A (enrdf_load_stackoverflow) |
| AU (1) | AU733475B2 (enrdf_load_stackoverflow) |
| WO (1) | WO1997030054A1 (enrdf_load_stackoverflow) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6291425B1 (en) | 1999-09-01 | 2001-09-18 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| US6774263B1 (en) | 1997-10-10 | 2004-08-10 | Cambridge Neuroscience, Inc. | Pharmaceutically active compound and methods of use |
| CA2306276A1 (en) * | 1997-10-10 | 1999-04-22 | James B. Fischer | Pharmaceutically active compound and methods of use |
| US20030232813A1 (en) * | 2002-04-10 | 2003-12-18 | Orchid Chemicals & Pharmaceuticals Limited | Novel amino substituted pyrimidinone derivatives |
| US7417040B2 (en) | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
| DE102005027168A1 (de) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Tetrahydrochinoline |
| CN114206860B (zh) * | 2019-06-07 | 2025-02-18 | 礼蓝动物保健有限公司 | 用于治疗体内寄生虫的双环衍生物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3314963A (en) * | 1962-07-23 | 1967-04-18 | Pfizer & Co C | Azabenzocycloalkane-n-carboxamidines |
| US3291799A (en) * | 1964-09-21 | 1966-12-13 | Hoffmann La Roche | Isoquinoline carboxamidine |
| FR1473839A (fr) * | 1965-04-02 | 1967-03-24 | Alphachimie | Nouveaux dérivés de la 2, 3, 4, 5-tétrahydro-(1h)-1-benzazépine et leurs procédés de fabrication |
| US3679692A (en) * | 1969-10-01 | 1972-07-25 | Mead Johnson & Co | Iminomethylindolines |
| US4504482A (en) * | 1983-07-28 | 1985-03-12 | Sterling Drug Inc. | [5(or 4)-(Pyridinyl)-2-pyrimidinyl]ureas and cardiotonic use thereof |
| DE4241806A1 (de) * | 1992-12-11 | 1994-06-16 | Hoechst Ag | Aromatisch substituierte Pyrimidinverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| CA2182302A1 (en) * | 1994-02-03 | 1995-08-10 | Stanley M. Goldin | Therapeutic guanidines |
-
1997
- 1997-02-14 JP JP9529602A patent/JP2000504730A/ja not_active Ceased
- 1997-02-14 WO PCT/US1997/002678 patent/WO1997030054A1/en not_active Application Discontinuation
- 1997-02-14 AU AU22780/97A patent/AU733475B2/en not_active Ceased
- 1997-02-14 EP EP97906923A patent/EP0925300A1/en not_active Withdrawn
- 1997-02-14 KR KR1019980706227A patent/KR19990082494A/ko not_active Ceased